Clinical Trial Update: Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 clinical evaluations of AL2846 Capsule for differentiated thyroid cancer have been completed. The study was sponsored by Chia Tai Tianqing P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• AL2846 Capsule (AL2846)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Differentiated Thyroid Cancer | Phase 1, Phase 2 | Status: COMPLETED